Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Not yet recruiting
- Conditions
- Diffuse Large B Cell LymphomaMultiple Myeloma
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT06323447
Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population
Completed
- Conditions
- Hematologic Malignancy
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT04889937
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Study to Evaluate the Usability of PointCheck
Completed
- Conditions
- NeoplasmsChemotherapy-induced Neutropenia
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT04448314
- Locations
- 🇪🇸
Hospital Universitari Dexeus. Grupo Quirónsalud, Barcelona, Spain
🇪🇸Breast Unit. Oncology Department. 12 Octubre Hospital, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
PC001- A Study to Evaluate the Usability of PointCheck
Not Applicable
Recruiting
- Conditions
- NeoplasmsNeutropenia
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04448301
- Locations
- 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States
News
No news found